The Silent Sufferer: Osteoarthritis (OA)

Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown and joint pain. This condition significantly impacts mobility, quality of life, and overall well-being. Accurate assessment of OA severity is crucial for effective treatment and management.

The High Cost of Osteoarthritis: A Silent Epidemic

The impact of OA extends far beyond physical pain. It can lead to reduced mobility, disability, and increased healthcare costs. The need for effective tools to assess OA severity and monitor disease progression is paramount to improving patient outcomes and reducing the overall burden of this condition.

Kribado: Your Partner in Osteoarthritis Management

Kribado is an innovative risk stratification and behavior setting device designed to address the challenges of osteoarthritis management. By accurately assessing OA severity using the WOMAC Osteoarthritis Index, Kribado empowers healthcare providers to develop personalized treatment plans and monitor disease progression.

This cutting-edge solution offers a non-invasive screening process that delivers instant WOMAC scores, enabling efficient patient triage and resource allocation. Kribado’s user-friendly interface and streamlined data collection ensure accurate and reliable results.

Indigital Technologies: Your Partner in Joint Health

Indigital Technologies is a leading pharmaceutical business growth expert with a proven track record of success. Our 9-year journey has involved collaborating with 653 pharmaceutical brands across 8 countries, generating over 9700 crores in revenue.

We are committed to developing innovative solutions that address critical healthcare challenges. With over 200 COAs and expertise across 12 therapeutic areas, Kribado represents our dedication to improving patient lives.